Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-035547
Filing Date
2025-03-07
Accepted
2025-03-07 16:30:08
Documents
1
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4274
  Complete submission text file 0000950170-25-035547.txt   5817
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address
Smethurst Dominic (Reporting) CIK: 0001820549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 25720533